VERSITI WISCONSIN INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1947

Legal Domicile

Principal Officer

CHRIS MISKEL

Phone

4149335000

Tax Period

2023-01-01 to 2023-12-31

VERSITI WISCONSIN INC, founded in 1947, is a major nonprofit in the Health Care sector that reported $235.2M in total revenue in fiscal year 2023.

Mission

VERSITI WISCONSIN, INC. (VERSITI) IS A BLOOD HEALTH INNOVATOR WHICH ENHANCES LIVES THROUGH DISCOVERY, DIAGNOSIS AND TREATMENT. VERSITI EXPANDS THE FRONTIERS OF PATIENT HEALTH THROUGH THE INTEGRATION OF SCIENCE, MEDICINE AND SERVICE.

Program Service Accomplishments

Program 1

Expenses: $48,514,048 Revenue: $54,436,294

VERSITI OPERATES THE COMPREHENSIVE CENTER FOR BLEEDING DISORDERS (CCBD), UNDER A FEDERAL SUBAWARD AGREEMENT OF THE SOCIAL SECURITY ACT. CCBD PROVIDES CRITICAL SERVICES TO BLEEDING AND CLOTTING...

VERSITI OPERATES THE COMPREHENSIVE CENTER FOR BLEEDING DISORDERS (CCBD), UNDER A FEDERAL SUBAWARD AGREEMENT OF THE SOCIAL SECURITY ACT. CCBD PROVIDES CRITICAL SERVICES TO BLEEDING AND CLOTTING DISORDER PATIENTS AND THEIR FAMILIES. AS A COVERED ENTITY UNDER THE FEDERAL 340B DRUG DISCOUNT PROGRAM, VERSITI IS ELIGIBLE TO ACCESS CERTAIN SPECIALTY PHARMACEUTICALS AT DISCOUNTED PRICING. PHARMACEUTICAL NET INCOME IS PROGRAM INCOME AND FUNDS ARE RESTRICTED TO ACTIVITIES AND EXPENDITURES THAT FURTHER ELIGIBLE PROJECTS AND PROGRAM OBJECTIVES; INCLUDING PATIENT CARE, EDUCATION, SUPPORT SERVICES, APPROVED GRANT RESEARCH AND OTHER COSTS. VERSITI PROVIDES THESE SPECIALTY PHARMACY PRODUCTS TO HOME CARE PATIENTS AND HOSPITAL SYSTEMS. DURING 2023, 14,889 VIALS OF SPECIALTY PHARMACY PRODUCTS WERE PROVIDED.

Program 2

Expenses: $43,276,164 Revenue: $52,112,157

VERSITI RECRUITS VOLUNTEER BLOOD DONORS, COLLECTS, PROCESSES AND DISTRIBUTES BLOOD AND BLOOD COMPONENTS TO PROVIDE A SAFE AND RELIABLE SUPPLY OF BLOOD FOR HOSPITALS AND OTHER BLOOD CENTERS SERVED...

VERSITI RECRUITS VOLUNTEER BLOOD DONORS, COLLECTS, PROCESSES AND DISTRIBUTES BLOOD AND BLOOD COMPONENTS TO PROVIDE A SAFE AND RELIABLE SUPPLY OF BLOOD FOR HOSPITALS AND OTHER BLOOD CENTERS SERVED. DURING 2023, 149,369 BLOOD UNITS WERE COLLECTED.

Program 3

Expenses: $36,936,818 Revenue: $0

VERSITI RESEARCH ADVANCES THE SCIENTIFIC AND MEDICAL UNDERSTANDING OF BLOOD BIOLOGY AND BLOOD DISEASE TO IMPROVE HEALTH. DURING 2023, VERSITI HAD 34 INVESTIGATORS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $35,533,265

Program Service Revenue $195,099,800

Investment Income $3,894,142

Other Revenue $677,285

TOTAL REVENUE $235,204,492

Expense Breakdown

Grants Paid $3,971,528

Salaries & Benefits $99,706,668

Fundraising Expenses $0

Program Expenses $198,249,581

Other Expenses $127,290,428

TOTAL EXPENSES $230,968,624

Year-over-Year Comparison

	2023	2022	Change
Revenue	$235,204,492	$220,819,216	+0.1%
Expenses	$230,968,624	$207,344,800	+0.1%
Net Income	$4,235,868	$13,474,416	-0.7%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

1283

Volunteers

292

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$8,169,209

Total Directors

$1,480,476

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
CHRIS MISKEL	PRESIDENT & CEO	21.00	Officer Director	$598,543	$55,375	$1,480,476
FRED GEILFUSS	CHAIR; LEGAL ADVISOR	1.00	Officer Director	$0	$0	$0
L ALAN WHALEY	VICE CHAIR	1.00	Officer Director	$0	$0	$0
SHERRY HUSA	SECRETARY	1.00	Officer Director	$0	$0	$0
RON MILLER	TREASURER	1.00	Officer Director	$0	$0	$0
NICHOLAS BAUER	BOARD MEMBER - AS OF 3/23	1.00	Director	$0	$0	$0
COREEN DICUS-JOHNSON JD	BOARD MEMBER	1.00	Director	$0	$0	$0
DAVID GINSBURG MD	BOARD MEMBER	1.00	Director	$0	$0	$0
CECELIA GORE	BOARD MEMBER - AS OF 11/23	1.00	Director	$0	$0	$0
GAIL HANSON	BOARD MEMBER	1.00	Director	$0	$0	$0
THOMAS HAUSKE JR	BOARD MEMBER	1.00	Director	$0	$0	$0
DALE KENT	BOARD MEMBER	1.00	Director	$0	$0	$0
ROBERT H MANEGOLD	BOARD MEMBER	1.00	Director	$0	$0	$0
JEFFREY S MCDONALD	BOARD MEMBER	1.00	Director	$0	$0	$0
MAGGEY OPLINGER	BOARD MEMBER - AS OF 11/23	1.00	Director	$0	$0	$0
JOHN PERRAS	BOARD MEMBER	1.00	Director	$0	$0	$0
KATHY THORNTON-BIAS	BOARD MEMBER	1.00	Director	$0	$0	$0
GREG WESLEY	BOARD MEMBER	1.00	Director	$0	$0	$0
PETER ZIEGLER	BOARD MEMBER	1.00	Director	$0	$0	$0
BART REUTER	EVP & GENERAL COUNSEL	21.00	Officer	$302,795	$64,225	$785,165
ANTHONY WATKINS	EVP & CHIEF FINANCIAL OFFICER	21.00	Officer	$311,566	$40,131	$781,954
BRIAN BAUTISTA	EVP & CHIEF OPERATING OFFICER	22.00	Officer	$288,748	$54,302	$741,795
MICHAEL DEININGER MD	EVP & CHIEF SCIENTIFIC OFFICER	48.00	Officer	$611,478	$39,453	$683,113
GITESH DUBAL	EVP & CHIEF MARKETING OFFICER	22.00	Officer	$260,471	$56,985	$677,152
BRADLEY PIETZ	EVP & CHIEF LABORATORY OFFICER	22.00	Officer	$232,428	$62,979	$616,384
BARBARA BRYANT	EVP & CHIEF MEDICAL OFFICER	50.00	Officer	$546,023	$25,848	$571,871
JAMES WEIDNER	EVP & CHIEF HR OFFICER	22.00	Officer	$214,033	$54,653	$564,260
ALEXANDRA PIEPER	VP & CHIEF QLT OFF - THRU 10/23	22.00	Officer	$218,935	$42,404	$563,684
LYNNE BRIGGS	VP & CHIEF INFORMATION OFFICER	22.00	Officer	$199,119	$50,984	$525,083
JESSICA DROUILLARD	VP & CHIEF QLT OFF - AS OF 10/23	22.00	Officer	$69,419	$12,988	$178,272
MATTHEW ANDERSON MD	VP & DIAGNOSTIC LAB MED DIRECTOR	55.00	Highest	$449,993	$63,620	$513,613
PETER NEWMAN PHD	VP RESEARCH & ASSOC DIR BRI	55.00	Highest	$410,742	$39,073	$449,815
KARIN HOFFMEISTER	DEPUTY DIRECTOR VBRI	55.00	Highest	$367,763	$48,731	$416,494
LYNN M MALEC MD	SENIOR MEDICAL DIRECTOR	55.00	Highest	$373,341	$40,023	$413,364
LISA BAUMANN KREUZIGER	SENIOR MEDICAL DIRECTOR	55.00	Highest	$371,996	$39,360	$411,356

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$235,204,492	$230,968,624	$188,812,448	$4,235,868
2022	$220,819,216	$207,344,800	$141,863,484	$13,474,416
2021	$196,362,715	$196,030,853	$138,704,162	$331,862
2020	$186,827,160	$186,240,771	$135,380,410	$586,389
2019	$172,523,164	$175,790,517	$123,459,642	$-3,267,353